Previous studies have shown that spinal cord stimulation (SCS) of upper lumbar segments decreases visceromotor responses to mechanical stimuli in a sensitized rat colon and reduces symptoms of irritable bowel syndrome in patients. SCS applied to the upper cervical spinal dorsal column reduces pain of chronic refractory angina. Further, chemical stimulation of C1-C2 propriospinal neurons in rats modulates the responses of lumbosacral spinal neurons to colorectal distension. The present study was designed to compare the effects of upper cervical and lumbar SCS on activity of lumbosacral neurons receiving noxious colorectal input. Extracellular potentials of L6-S2 spinal neurons were recorded in pentobarbital anesthetized, paralyzed and ventilated male rats. SCS (50 Hz, 0.2 ms) at low intensity (90% of motor threshold) was applied to the dorsal column of upper cervical (C1-C2) or upper lumbar (L2-L3) ipsilateral spinal segments. Colorectal distension (CRD, 20 mmHg, 40 mmHg, 60 mmHg, 20 s) was produced by air inflation of a latex balloon. Results showed that SCS applied to L2-L3 and C1-C2 segments significantly reduced the excitatory responses to noxious CRD from 417.6 AE 68.0 to 296.3 AE 53.6 imp (P < 0.05, n = 24) and from 336.2 AE 64.5 to 225.0 AE 73.3 imp (P < 0.05, n = 18), respectively. Effects of L2-L3 and C1-C2 SCS lasted 10.2 AE 1.9 and 8.0 AE 0.9 min after offset of CRD. Effects of SCS were observed on spinal neurons with either high or low-threshold excitatory responses to CRD. However, L2-L3 or C1-C2 SCS did not significantly affect inhibitory neuronal responses to CRD. C1-C2 SCS-induced effects were abolished by cutting the C7-C8 dorsal column but not by spinal transection at cervicomedullary junction. These data demonstrated that upper cervical or lumbar SCS modulated responses of lumbosacral spinal neurons to noxious mechanical stimulation of the colon, thereby, proved two loci for a potential therapeutic effect of SCS in patients with irritable bowel syndrome and other colonic disorders. #
Introduction
During the last three decades, spinal cord stimulation (SCS) has become a therapy used for treating certain chronic pains, such as neuropathic pain and ischemic pain (Cameron, 2004; Meyerson and Linderoth, 2000a,b) . Various neurophysiological and neurochemical mechanisms underlying the beneficial effects of SCS have also been proposed (Linderoth and Foreman, 1999, 2006) . In general, electric stimulation to the dorsal column, which contains large diameter afferent fibers, inhibits transmission of nociceptive information at the spinal segmental level. This finding implicates elements of the gatecontrol theory (Melzack and Wall, 1965) , although activation of supraspinal circuits may also be involved (El-Khoury et al., 2002) . Several experimental studies have been performed to explore effects of SCS on spinal neuronal processing of noxious somatic inputs. For example, SCS mainly suppresses excitatory responses of spinothalamic tract neurons (STT) and spinal neurons to noxious somatic stimuli in monkeys (Foreman et al., 1976) and cats (Lindblom et al., 1977) , attenuates dorsal horn neuronal hyperexcitability in rats with mononeuropathy (Yakhnitsa et al., 1999) , and inhibits long-term potentiation of spinal dynamic range neurons in rats (Wallin et al., 2003) .
The mechanisms evoked by SCS have primarily addressed relief of somatic pain, particularly neuropathic pain. However, few studies have examined effects of SCS on visceroreceptive transmission in the spinal cord. Indeed, SCS is used in patients to treat chronic refractory angina (Eliasson et al., 1996;  www.elsevier.com/locate/neures Neuroscience Research 58 (2007) 58-66 
